2 results match your criteria: "Gillis W. Long Hansen's Disease Center at Louisiana State University[Affiliation]"
Bactericidal action of oral ampicillin/sulbactam against Mycobacterium leprae.
J Antimicrob Chemother
August 1999
Gillis W. Long Hansen's Disease Center at Louisiana State University, US Public Health Service, Baton Rouge 70894-5072, USA.
We reported previously that an injectable form of ampicillin/sulbactam, Unasyn, was bactericidal to Mycobacterium leprae multiplying in mouse foot pads. In this study, we examined the effect of an orally active form of ampicillin/sulbactam, Sultamicillin, on the growth of M. leprae in mice.
View Article and Find Full Text PDFEvaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens.
Clin Infect Dis
February 1998
Molecular Biology Research Department, Gillis W. Long Hansen's Disease Center at Louisiana State University, Baton Rouge 70894, USA.
In a double-blind study, 655 sputum specimens were obtained from individuals suspected of having tuberculosis and were analyzed for the presence of Mycobacterium tuberculosis and rifampin susceptibility with use of a polymerase chain reaction (PCR)-based universal heteroduplex generator assay (PCR/UHG-Rif). Of the specimens containing viable M. tuberculosis, 100% of the smear-positive (n = 41) and 50% of the smear-negative (n = 6) specimens tested positive for the organism by PCR/UHG-Rif.
View Article and Find Full Text PDF